等待开盘 10-23 09:30:00 美东时间
-0.380
-0.61%
Globus Medical has launched the ANTHEM™ Elbow Fracture System, a comprehensive solution for treating various elbow fractures. Featuring 14 plate families, screw options, and anatomical instruments, the system simplifies surgeries and offers versatility for complex fractures. With polyaxial locking technology enabling flexible screw placement, the ANTHEM™ System enhances fixation accuracy. surgeons praise its design and flexibility, highlighting i...
10-14 20:40
Globus Medical, a leading musculoskeletal technology company, announced that a Delaware jury ruled in its favor in a patent infringement case against Life Spine, Inc. The jury found Life Spine's Prolift implants infringed Globus' valid patent and awarded both lost profits and reasonable royalty damages. The technology in question involves expandable spinal fusion implants, which improve patient outcomes in spinal surgery. Keith Pfeil, President a...
08-28 20:30
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.
08-19 02:25
Gray Media, Inc. has reached an agreement with the Fox Television Network to extend and renew affiliations for all of its Fox-affiliated television stations in 27 markets, including Portland, Oregon; Cincinnati, Ohio; Las Vegas, Nevada; and Birmingham, Alabama. Gray Media is the largest owner of top-rated local television stations in the U.S., serving 113 markets and reaching approximately 37% of U.S. television households. The company also opera...
08-18 11:00
Wells Fargo analyst Vik Chopra maintains Globus Medical (NYSE:GMED) with a Overweight and lowers the price target from $76 to $66.
08-08 23:23
Major earnings expected after the bell on Thursday include: Block (XYZ) Gilead Sciences (GILD) Twilio (TWLO) The Trade Desk (TTD) Main Street Capital Corporation (MAIN) Other earnings slated for rele...
08-07 22:00
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Canaccord Genuity analyst William Plovanic maintains Globus Medical (NYSE:GMED) with a Buy and lowers the price target from $97 to $90.
07-22 22:14
Needham analyst David Saxon reiterates Globus Medical (NYSE:GMED) from Hold to Hold.
07-21 23:38
The latest announcement is out from Globus Medical ( ($GMED) ). On July 18, 202...
07-21 20:52